CIK: 0001826434
Total reported value
$712.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | Stock-Healthcare | 16.21% | -1.99% | +99.17% | |
| 2 | DHR | Danaher CORP | Stock-Healthcare | 10.31% | -10.31% | EXIT | |
| 3 | LLY | Eli Lilly & Co | Stock-Healthcare | 8.83% | -0.85% | — | |
| 4 | UTHR | United Therapeutics CORP | Stock-Healthcare | 7.65% | -1.79% | -1.04% | |
| 5 | ASND | Ascendis Pharma A/S | Stock-Other | 7.34% | +0.86% | +51.59% | |
| 6 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 6.50% | +1.09% | +27.05% | |
| 7 | BSX | Boston Scientific CORP | Stock-Healthcare | 6.44% | -6.44% | EXIT | |
| 8 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 5.82% | -1.50% | — | |
| 9 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 5.72% | -5.72% | EXIT | |
| 10 | VERA | Vera Therapeutics INC | Stock-Other | 5.30% | -5.30% | EXIT | |
| 11 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 4.78% | -3.31% | -30.98% | |
| 12 | ARGX | Argenx Se - Adr | Stock-Healthcare | 4.11% | -0.87% | -13.26% | |
| 13 | NUVL | Nuvalent Inc-a | Stock-Other | 4.01% | +0.43% | — | |
| 14 | DXCM | Dexcom INC | Stock-Healthcare | 3.63% | +2.52% | — | |
| 15 | DNTH | Dianthus Therapeutics INC | Stock-Other | 3.33% | -1.62% | +240.36% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | +3.3% | +99.17% | Add |
| 2 | DNTH | Dianthus Therapeutics INC | +1.7% | +240.36% | Add |
| 3 | MDGL | Madrigal Pharmaceuticals INC | -0.6% | +27.05% | Add |
| 4 | ASND | Ascendis Pharma A/S | -0.7% | +51.59% | Add |
| 5 | VERA | Vera Therapeutics INC | -2.7% | -32.31% | Trim |
| 6 | ARGX | Argenx Se - Adr | -3.3% | -13.26% | Trim |
| 7 | AXSM | Axsome Therapeutics INC | -3.4% | -30.98% | Trim |
| 8 | UTHR | United Therapeutics CORP | -4.1% | -1.04% | Trim |
| 9 | DHR | Danaher CORP | — | NEW | New buy |
| 10 | LLY | Eli Lilly & Co | — | NEW | New buy |
| 11 | BSX | Boston Scientific CORP | — | NEW | New buy |
| 12 | TEVA | Teva Pharmaceutical-sp Adr | — | NEW | New buy |
| 13 | IONS | Ionis Pharmaceuticals INC | — | NEW | New buy |
| 14 | MRK | Merck & Co. INC. | — | EXIT | Sold out |
| 15 | NUVL | Nuvalent Inc-a | — | NEW | New buy |
| 16 | SLNOEUR | Soleno Therapeutics INC | — | EXIT | Sold out |
| 17 | DXCM | Dexcom INC | — | NEW | New buy |
| 18 | ABBV | Abbvie INC | — | EXIT | Sold out |
| 19 | KRRO | Korro Bio INC | — | EXIT | Sold out |
| 20 | XENE | Xenon Pharmaceuticals INC | — | EXIT | Sold out |
| 21 | ✓ | Avadel Pharmaceu | — | EXIT | Sold out |
| 22 | STVN | Stevanato Group S.p.A. | — | EXIT | Sold out |
| 23 | TARS | Tarsus Pharmaceuticals INC | — | EXIT | Sold out |
| 24 | PRAX | Praxis Precision Medicines I | — | EXIT | Sold out |
| 25 | BHVN | Biohaven Ltd. | — | EXIT | Sold out |